Mordechai Algrably
Chief Executive Officer presso REKAH PHARMACEUTICAL INDUSTRY LTD.
Patrimonio netto: 7 M $ in data 31/03/2024
Profilo
Mordechai Algrably is the founder of Ophir Ltd., which was founded in 1992.
He is currently the Chief Executive Officer & Director at Rekah Pharmaceutical Industry Ltd.
and the Chairman & President at Rekah Group.
Mr. Algrably's education includes an undergraduate degree from The Hebrew University of Jerusalem.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/09/2023 | 1 748 439 ( 15.17% ) | 7 M $ | 31/03/2024 |
Posizioni attive di Mordechai Algrably
| Società | Posizione | Inizio |
|---|---|---|
| REKAH PHARMACEUTICAL INDUSTRY LTD. | Chief Executive Officer | 24/08/1993 |
| Rekah Group | Chairman | 28/06/2010 |
| Ophir Ltd. | Founder | 28/06/2010 |
Formazione di Mordechai Algrably
| The Hebrew University of Jerusalem | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
| Rekah Pharmaceutical Industry Ltd. | |
| Rekah Group | |
| Ophir Ltd. |
- Borsa valori
- Insiders
- Mordechai Algrably
